Prevalence and Risk Factors Associated with Frailty Syndrome in Chronic Heart Failure Patients at Heart Failure Clinic at Vajira Hospital
Journal Title: Vajira Medical Journal: Journal of Urban Medicine - Year 2024, Vol 68, Issue 3
Abstract
OBJECTIVE: The prevalence of frailty syndrome in patients with chronic heart failure (HF) at Vajira Hospital was investigated, and risk factors associated with frailty syndrome and chronic HF were identified for optimizing management and improving outcomes in this vulnerable population. METHODS: A prospective cross-sectional study was conducted at chronic HF clinic of Vajira Hospital by history taking, collecting data with questionnaires, and performing specific tests (Fried Frailty Phenotype). Echocardiogram and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were obtained from chronic HF patients from January 2022 to December 2023. A physician collected clinical data and baseline characteristics. All patients were tested for the Fried Frailty Phenotype by a physical therapist. Determinants were evaluated using univariate and multivariate logistic regression models. RESULTS: A total of 94 patients were enrolled. The prevalence of frailty syndrome in patients with HF was 27.70% (95% CI: 18.90–37.80). Univariate analysis showed that factors associated with increased likelihood of frailty syndrome in patients with chronic HF included chronic kidney disease (CKD stages IV–V, unadjusted OR = 4.00, 95% CI: 1.11–14.43, p-value = 0.03), New York Heart Association (NYHA; III–IV, unadjusted OR = 39.00, 95% CI: 8.30–183.29, p-value < 0.001), left ventricular ejection fraction (≤ 40%, unadjusted OR = 3.84, 95% CI: 1.13–13.02, p-value = 0.031), NT-proBNP (> 1000 pg/mL, unadjusted OR = 5.50, 95% CI: 1.71–17.66, p-value = 0.004) and diuretics (unadjusted OR = 8.33, 95% CI: 1.05–66.22, p-value = 0.045) but multivariate analysis showed only NYHA (III-IV), adjusted OR = 30.51, 95% CI: 6.01–154.94, p-value < 0.001) increase risk of frailty syndrome. CONCLUSION: The prevalence of frailty syndrome in patients with chronic HF was found, and the main associated factor affecting frailty is NYHA(III-IV). NYHA classification and frailty in HF patients are crucial for comprehensive management. Regular assessment of NYHA class, frailty status, and associated factors (physical, cognitive, nutritional, and psychosocial) is essential for personalized care planning.
Authors and Affiliations
Torlarp Kunapornpiroj, Wichada Hunsakunachai, Khanistha Wattanananont
Keywords
Related Articles
- EP ID EP743207
- DOI http://dx.doi.org/10.62691/vmj.2024.269058
- Views 57
- Downloads 0
Resilience, Mental Health Impact and COVID-19 Related Mental Health Determinants among Medical Students during COVID-19 Epidemic
Objective: To study the level of resilience in medical students and how resilience is associated with mental health during COVID-19 epidemic. Method: This is a cross-sectional descriptive study. The participants are the...
Factors Affecting Dental Health Behaviors in Patients Using Removable Partial Dentures
OBJECTIVE: To study the dental health behaviors and factors affecting the dental health behaviors of patients using removable partial dentures (RPDs). METHODS: A cross-sectional descriptive study was conducted with 650...
Prevalence and Risk Factors of Chloroquine and Hydroxychloroquine Retinopathy
Objective: To evaluate the prevalence and risk factors of chloroquine and hydroxychloroquine retinopathy. Methods: Retrospective cohort study was conducted at Vajira hospital. Medical records of autoimmune patients who...
Efficacy and Adverse Effects of Sodium Phosphate and Polyethylene Glycol When Used in Bowel Preparation prior to Colonoscopy among Patients Admitted at Vajira Hospital
Objective: Bowel preparation is an important process before colonoscopy. Sodium phosphate (NaP) and polyethylene glycol (PEG) are the drugs mainly used in bowel preparation at Vajira Hospital. Since NaP is an osmotic lax...
Antibody Response after ChAdOx1 nCoV-19 Vaccination in Patients with Type 2 Diabetes at Vajira Hospital
OBJECTIVE: A question exists as to whether people with diabetes can respond effectively to the COVID-19 vaccine. This study aimed to evaluate antibody response after COVID-19 vaccination in patients with type 2 diabetes....